Last reviewed · How we verify
Fluorsalan (flusalan)
Fluorsalan (generic name: flusalan) is a flusalan drug. It is currently in unknown development.
Fluorsalan works by binding to and activating kappa-type opioid receptors in the brain, which can help reduce pain without the same risks as traditional opioids.
Fluorsalan, also known as flusalan, is a small molecule drug class targeting the kappa-type opioid receptor. It is currently owned by an unknown entity, and its commercial status is unclear. Fluorsalan is being developed to treat various conditions, but its exact indications and approval status are unknown. As a kappa opioid receptor agonist, fluorsalan works by binding to and activating these receptors, which can produce analgesic effects without the same level of respiratory depression as traditional opioids. Further research is needed to fully understand its safety and efficacy profile.
At a glance
| Generic name | flusalan |
|---|---|
| Drug class | flusalan |
| Target | Kappa-type opioid receptor, Mu-type opioid receptor |
| Therapeutic area | Pain |
| Phase | unknown |
Mechanism of action
Imagine your brain has special locks that control pain signals. Fluorsalan is a key that fits into these locks, called kappa opioid receptors, and turns them on to help reduce pain. This can be helpful for people who need pain relief without the risks of other opioids.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fluorsalan CI brief — competitive landscape report
- Fluorsalan updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Fluorsalan
What is Fluorsalan?
How does Fluorsalan work?
What is the generic name of Fluorsalan?
What drug class is Fluorsalan in?
What development phase is Fluorsalan in?
What does Fluorsalan target?
Related
- Drug class: All flusalan drugs
- Target: All drugs targeting Kappa-type opioid receptor, Mu-type opioid receptor
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Pain
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing